CLINICAL_TRIALS
research
· 2017-01-10
Clinical Trial Update: The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular Meshwork [NA]
Summary
The study investigates expression levels of matrix metalloproteinase-13, tissue inhibitor of metalloproteinases-3, and calcium-sensing receptor in the human tra…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lv Yingjuan | Conditions: Open-angle Glaucoma | NA | Status: COMPLETED